Medolife Rx, Inc., a majority owned subsidiary of Quanta, Inc. announced In a recent study, a total of 400 patients in the Dominican Republic - where, a majority tested positive for COVID-19, and a small portion were COVID-19 symptomatic even though they tested negative for COVID-19 - reported a 100 percent improvement in symptoms after being administered Escozine®.
January 27, 2021
· 6 min read